lintopride

a 5HT-4 antagonist; structure given in first source

Also Known As:

4-amino-5-chloro-N-((1-ethylimidazolin-2-yl)methyl)-2-methoxybenzamide; ACEMM

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Chest Pain (Chest Pains) 10/01/1995 - "Eight healthy male volunteers, mean age 22 (19-28) years, without any history of digestive disease or chest pain, were randomized to three doses of lintopride (0.1, 0.3 and 0.5 mg/kg i.v.) and a placebo at 1-week intervals in a double-blind, crossover study. "